Lv5
880 积分 2025-07-01 加入
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
21天前
已完结
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
21天前
已完结
ALK in cancer: from function to therapeutic targeting
21天前
已完结
ALK alterations and inhibition in lung cancer
21天前
已完结
Lung cancer in patients who have never smoked — an emerging disease
21天前
已完结
Using a combination of superb microvascular imaging and other auxiliary ultrasound techniques to increase the accuracy of gray-scale ultrasound for breast masses
22天前
已完结
ALK alterations and inhibition in lung cancer
28天前
已完结
The changing therapeutic landscape of small-cell lung cancer
1个月前
已完结
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
1个月前
已完结
Tumor cells impair immunological synapse formation via central nervous system-enriched metabolite
1个月前
已完结